Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ekokobe Fonkem DO

Ekokobe Fonkem DO profile photo picture

Chair, Professor

Institution: Medical College of Wisconsin
Department: Neurology
Division: Administration

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0001-6382-8866

Member of the Cancer Center
Member of the Wisconsin Institute of NeuroScience (WINS)


I am willing to collaborate on research projects.
I am willing to be a peer mentor.
I am willing to mentor a junior faculty member.

View Curriculum Vitae

Research Areas of Interest

  • Neuro-Genomics (Rare Neurological Disorders and Complex Traits)
  • Pharmacogenomics (Efficacy, Toxicity/ADR and PK/Metabolism of Neurology and Neuro-oncology drugs)
  • Brain Tumor Registry and Biobanking
  • Translational Neurology-Oncology (Therapeutic Target Validation and Clinical Trials)
  • Microbiome in Neurology and Neuro-oncology
  • Neurology Phenotype Ontology

    • Research Experience

  • Molecular Targets and Therapeutics and Clinical Trials
  • Genetic susceptibility to Brain Tumor, Spinal Tumor and Neurofibromatosis.
  • Pharmacogenomics and Precision Health in Neurology and Neuro-oncology

    • Clinical Expertise

  • Neurology
  • Neuro-oncology

    • Methodologies and Techniques

  • Translational Research
  • Clinical Implementation
  • Basic Science Research

    • Leadership Positions

  • Professor of Neurology, Neurosurgery and Oncology. Department of Neurology, Medical College of Wisconsin.
  • Chair. Department of Neurology, Medical College of Wisconsin.

    • MCW Program / Core Facilities

  • PRECISE NEUROLOGY - Precision Health Research Neurology

    • Educational Expertise

  • Internal Medicine, 2008, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Doctor of Osteopathic Medicine, 2007, Ohio University College of Osteopathic Medicine, Athens, OH, USA.
  • Bachelor of Science (BSc) in Biochemistry (Magna cum laude), 2002, University of Wisconsin-Madison, Madison, WI, USA.
  • Pre-Medicine (AA), 2000, University of Wisconsin Colleges, Fox Valley, WI.
  • Neuro-oncology, 2012, Harvard University Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Neurology, 2011, Ohio State University Wexner Medical Center, Columbus, OH, USA.

    • Community Partnerships

  • Member of the Health Committee. Lebang Cultural and Development Organization (LECUDO), USA.
  • Founder and CEO. Healing Beyond the Horizon
  • Special Adviser and Content Expert. “Better Place Foundation”. Dedicated to finding the Cure for Brain Tumor
  • Special Adviser to HE Ambassador Dr. John Nkengasong. Health Related Issues in Cameroon and Sub-Sahara Africa.
  • Member of the Advisory Board. Chris Elloit Brain Foundation

    • Publications (74)

  • An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma. (Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S) CNS Oncol 2023 Sep 01;12(3):CNS102 PMID: 37462385 PMCID: PMC10410686 SCOPUS ID: 2-s2.0-85169023261 07/18/2023       1 Citation
  • Gender and racial disparities in the incidence and mortality of pancreatic cancer in Mississippi State from 2003 to 2019. (Nduma B, Ambe S, Ekhator C, Fonkem E) J Gastrointest Oncol 2023 Jun 30;14(3):1478-1487 PMID: 37435219 PMCID: PMC10331749 SCOPUS ID: 2-s2.0-85166104288 07/12/2023       1 Citation
  • Endoscopic Gastric Sleeve: A Review of Literature. (Nduma BN, Mofor KA, Tatang JT, Ekhator C, Ambe S, Fonkem E) Cureus 2023 Mar;15(3):e36353 PMID: 37082499 PMCID: PMC10112045 04/21/2023    
  • The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. (Nduma BN, Mofor KA, Tatang J, Ekhator C, Ambe S, Fonkem E) Cureus 2023 Mar;15(3):e36148 PMID: 37065370 PMCID: PMC10101654 04/18/2023    
  • Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox. (Tadipatri R, Ekhator C, Narayan R, Azadi A, Yuen KCJ, Grewal J, Fonkem E) Neurooncol Pract 2023 Apr;10(2):169-175 PMID: 36970173 PMCID: PMC10037938 03/28/2023    
  • Safety and Efficacy of Radiofrequency Ablation and Epidural Steroid Injection for Management of Cervicogenic Headaches and Neck Pain: Meta-Analysis and Literature Review. (Ekhator C, Urbi A, Nduma BN, Ambe S, Fonkem E) Cureus 2023 Feb;15(2):e34932 PMID: 36938280 PMCID: PMC10016315 03/21/2023    
  • Supportive care of neurodegenerative patients. (Armitage AE, Fonkem E) Front Oncol 2023;13:1029938 PMID: 36865803 PMCID: PMC9974138 SCOPUS ID: 2-s2.0-85149559098 03/04/2023       1 Citation
  • Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers. (Qi D, Geng Y, Cardenas J, Gu J, Yi SS, Huang JH, Fonkem E, Wu E) NPJ Genom Med 2023 Jan 25;8(1):2 PMID: 36697401 PMCID: PMC9877004 SCOPUS ID: 2-s2.0-85146831078 01/26/2023       2 Citations
  • The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profiling. (Kelly RJ, Whitsett TG, Snipes GJ, Dobin SM, Finholt J, Settele N, Priest EL, Youens K, Wallace LB, Schwartz G, Wong L, Henderson SM, Gowan AC, Fonkem E, Juarez MI, Murray CE, Wu J, Van Keuren-Jensen K, Pirrotte P, Highlander S, Contente T, Baker A, Victorino J, Berens ME) Proc (Bayl Univ Med Cent) 2023;36(1):1-7 PMID: 36578607 PMCID: PMC9762845 SCOPUS ID: 2-s2.0-85136612332 12/30/2022    
  • Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report. (Tadipatri R, Eschbacher J, Fonkem E, Kresl J, Azadi A) Cureus 2022 Nov;14(11):e31449 PMID: 36523718 PMCID: PMC9747057 12/17/2022    
  • Assessment and prediction of glioblastoma therapy response: challenges and opportunities. (Qi D, Li J, Quarles CC, Fonkem E, Wu E) Brain 2023 Apr 19;146(4):1281-1298 PMID: 36445396 PMCID: PMC10319779 SCOPUS ID: 2-s2.0-85152389552 11/30/2022       4 Citations
  • Geographical Distribution of Pancreatic Cancer in the State of Mississippi by Incidence and Mortality From 2003 to 2019. (Nduma BN, Ambe S, Ekhator C, Fonkem E) Cureus 2022 Nov;14(11):e31605 PMID: 36408314 PMCID: PMC9671138 11/22/2022    
  • Falling Trend in the Epidemiology of Gastric Cancer in Mississippi From 2003 to 2019: What Mississippi Got Right. (Nduma BN, Ambe S, Ekhator C, Fonkem E) Cureus 2022 Nov;14(11):e31440 PMID: 36408310 PMCID: PMC9658492 11/22/2022    
  • Health Records Database and Inherent Security Concerns: A Review of the Literature. (Basil NN, Ambe S, Ekhator C, Fonkem E) Cureus 2022 Oct;14(10):e30168 PMID: 36397924 PMCID: PMC9647912 11/19/2022    
  • GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors. (Ekhator C, Nwankwo I, Rak E, Homayoonfar A, Fonkem E, Rak R) Cureus 2022 Oct;14(10):e29970 PMID: 36225241 PMCID: PMC9541893 10/14/2022    
  • A Single-Center Experience of Dopamine Antagonist ONC201 for Recurrent Histone H3 Lysine 27-to-Methionine (H3K27M)-Mutant Glioblastoma in Adults. (Ekhator C, Rak R, Tadipatri R, Fonkem E, Grewal J) Cureus 2022 Aug;14(8):e28175 PMID: 36148206 PMCID: PMC9482800 09/24/2022    
  • Ketogenic Metabolic Therapy for Glioma. (Smith KA, Hendricks BK, DiDomenico JD, Conway BN, Smith TL, Azadi A, Fonkem E) Cureus 2022 Jun;14(6):e26457 PMID: 35923675 PMCID: PMC9339381 08/05/2022    
  • The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges. (Ekhator C, Kesari S, Tadipatri R, Fonkem E, Grewal J) Cureus 2022 Jun;14(6):e25682 PMID: 35677741 PMCID: PMC9169580 06/10/2022    
  • Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT). (Leeper HE, Tonorezos E, Mayer D, Bakitas M, Chang S, Cooley ME, Hervey-Jumper S, Miaskowski C, Sherwood P, Tsien C, Wallgren K, Willmarth N, Arons D, Acquaye A, King AL, Penas-Prado M, Vera E, Gilbert MR, Armstrong TS, NCI-CONNECT Survivorship Care in Neuro-Oncology Workshop ) Neurooncol Adv 2022;4(1):vdac029 PMID: 35542753 PMCID: PMC9079897 SCOPUS ID: 2-s2.0-85134913906 05/12/2022       2 Citations
  • Overview of pathology and treatment of intramedullary spinal cord metastases (Fonkem E, Tadipatri R, Newton HB) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:59-63 SCOPUS ID: 2-s2.0-85159016636 01/01/2022    
  • Overview of pathology and treatment of metastatic brain tumors (Newton HB, Tadipatri R, Fonkem E) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:25-37 SCOPUS ID: 2-s2.0-85158994680 01/01/2022    
  • Overview of spinal cord tumour epidemiology (Fonkem E, Tadipatri R, Newton HB) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:39-43 SCOPUS ID: 2-s2.0-85158990484 01/01/2022    
  • Overview of pathology and treatment of primary brain tumours (Newton HB, Fonkem E) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:9-24 SCOPUS ID: 2-s2.0-85158989408 01/01/2022    
  • Overview of pathology and treatment of primary spinal cord tumours (Newton HB, Fonkem E) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:45-58 SCOPUS ID: 2-s2.0-85158976180 01/01/2022    
  • Overview of brain tumour epidemiology (Newton HB, Tadipatri R, Fonkem E) Handbook of Neuro-Oncology Neuroimaging 1 January 2022:3-8 SCOPUS ID: 2-s2.0-85147304363 01/01/2022       1 Citation
  • A Rare Case of Burkitt's Lymphoma Presenting With Features Mimicking Vogt-Koyanagi-Harada Disease. (Tadipatri R, Gonzalez D, Muley S, Fonkem E, Azadi A) Cureus 2021 Sep;13(9):e17659 PMID: 34646701 PMCID: PMC8487221 10/15/2021    
  • Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines. (Gatson NTN, Boccia ML, Taylor KR, Mack JKO, Fonkem E) Curr Oncol Rep 2021 Aug 27;23(11):127 PMID: 34453233 SCOPUS ID: 2-s2.0-85113691331 08/29/2021       2 Citations
  • SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology. (Chukwueke UN, Vera E, Acquaye A, Hervey-Jumper SL, Odia Y, Klesse LJ, Dunbar E, Sharma A, Fonkem E, Thomas AA, Werbowetski-Ogilvie TE, Camelo-Piragua S, Gatson NTN, de la Fuente MI, Armstrong TS, Porter AB, Jackson S) Neuro Oncol 2021 Nov 02;23(11):1845-1858 PMID: 34302487 PMCID: PMC8563326 SCOPUS ID: 2-s2.0-85119261153 07/25/2021       8 Citations
  • Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. (Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW) Endocrinol Diabetes Metab 2021 Jul;4(3):e00246 PMID: 34268454 PMCID: PMC8250331 SCOPUS ID: 2-s2.0-85102201015 07/17/2021       1 Citation
  • The need for a central brain tumor registry in Africa: A review of central nervous system tumors in Africa from 1960 to 2017. (Mbi Feh MK, Lyon KA, Brahmaroutu AV, Tadipatri R, Fonkem E) Neurooncol Pract 2021 Jun;8(3):337-344 PMID: 34055381 PMCID: PMC8153807 SCOPUS ID: 2-s2.0-85107966201 06/01/2021       9 Citations
  • Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapy. (Gatson NTN, Makary M, Bross SP, Vadakara J, Maiers T, Mongelluzzo GJ, Leese EN, Brimley C, Fonkem E, Mahadevan A, Sarkar A, Panikkar R) Neurooncol Pract 2021 Jun;8(3):247-258 PMID: 34055372 PMCID: PMC8153815 SCOPUS ID: 2-s2.0-85107956471 06/01/2021       2 Citations
  • Neuro-Oncology Palliative Care Survey of Physicians in Sub-Saharan Africa. (Tadipatri R, Azadi A, Cowdrey M, Fongue SF, Smith P, Razis E, Boccia M, Ghouri Y, Zozzaro-Smith P, Fonkem E) J Pain Symptom Manage 2021 Nov;62(5):1020-1025 PMID: 33933624 SCOPUS ID: 2-s2.0-85109077188 05/03/2021       5 Citations
  • Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic. (Fonkem E, Gatson NTN, Tadipatri R, Cole S, Azadi A, Sanchez M, Stefanowicz E) Neurooncol Pract 2021 Apr;8(2):109-116 PMID: 33889416 PMCID: PMC7665592 SCOPUS ID: 2-s2.0-85105575941 04/24/2021       5 Citations
  • An Exploratory Study of the Frequency of Central Nervous System Tumors by Type in the Central Texas Military and Civilian Populations. (Murillo J, Artz J, Brahmaroutu A, Gunnell S, Benge J, Lyon K, Fonkem E) Cureus 2021 Mar 14;13(3):e13885 PMID: 33868849 PMCID: PMC8043054 04/20/2021    
  • Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Fonkem E, Peng S, Berens M, Mukherjee S) J Neuropathol Exp Neurol 2021 Feb 22;80(3):290-291 PMID: 33617648 SCOPUS ID: 2-s2.0-85102020566 02/23/2021       1 Citation
  • A Preliminary Report on Quality of Life and Sexual Function in Brain Tumor Patients. (Boccia ML, Anyanda EI, Fonkem E) J Sex Med 2021 Apr;18(4):737-742 PMID: 33563548 SCOPUS ID: 2-s2.0-85100556675 02/11/2021       6 Citations
  • Racial Disparities in Malignant Primary Brain Tumor Survival in Texas From 1995 to 2013. (Ambe S, Lyon KA, Oh J, Rogers MKN, Olanipekun O, Basil NN, Fonkem E) Cureus 2020 Nov 25;12(11):e11710 PMID: 33391943 PMCID: PMC7769829 01/05/2021    
  • Incidence of Primary Central Nervous System Tumors Among the Hispanic Population in Texas 1995-2013. (Ambe S, Nizamutdinov D, Huang JH, Fonkem E) Cureus 2020 Sep 03;12(9):e10235 PMID: 33042676 PMCID: PMC7535946 10/13/2020    
  • Demographics of Astrocytoma in Central Texas: The Interaction Between Race, Histology, and Primary Tumor Site. (Nizamutdinov D, Dayawansa S, Fonkem E, Huang JH) Cureus 2020 Aug 11;12(8):e9676 PMID: 32923271 PMCID: PMC7486020 09/15/2020    
  • Optimum treatment for primary intracranial Ewing sarcoma. (Howell SG, Lyon KA, Garrett D Jr, Huang JH, Fonkem E) Proc (Bayl Univ Med Cent) 2020 Jul;33(3):430-432 PMID: 32675975 PMCID: PMC7340410 SCOPUS ID: 2-s2.0-85084294286 07/18/2020       2 Citations
  • Extraneural metastatic anaplastic ependymoma: a systematic review and a report of metastases to bilateral parotid glands. (Umbach G, El Ahmadieh TY, Plitt AR, Aoun SG, Neeley OJ, Lyon KA, Fonkem E, Raisanen JM, Bishop JA, Wardak Z, Patel TR, Myers L, Mickey BE) Neurooncol Pract 2020 Mar;7(2):218-227 PMID: 32626590 PMCID: PMC7318859 SCOPUS ID: 2-s2.0-85083974860 07/07/2020       11 Citations
  • SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Mukherjee S, Stroberg E, Wang F, Morales L, Shan Y, Rao A, Huang JH, Wu E, Fonkem E) J Neuropathol Exp Neurol 2020 May 01;79(5):562-565 PMID: 32296843 PMCID: PMC7160617 SCOPUS ID: 2-s2.0-85085284919 04/17/2020       5 Citations
  • A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma. (Tadipatri R, Lyon K, Azadi A, Fonkem E) Chin Clin Oncol 2021 Aug;10(4):35 PMID: 32279523 SCOPUS ID: 2-s2.0-85113495737 04/14/2020       1 Citation
  • An Update on Immune Checkpoint Inhibitor-related Hypophysitis (Mortensen MJ, Oatman O, Azadi A, Fonkem E, Yuen KC) US Endocrinology 2020;16(2):117-124 SCOPUS ID: 2-s2.0-85100545754 01/01/2020       3 Citations
  • Outcomes with acyclovir treatment in herpes simplex encephalitis after surgery for solid CNS tumors: a case report and systematic review of the literature. (Yari N, Benardete EA, Chen W, Ambe SN, Fonkem E) Neurooncol Pract 2019 Jul;6(4):259-263 PMID: 31386089 PMCID: PMC6660819 SCOPUS ID: 2-s2.0-85073904497 08/07/2019       1 Citation
  • Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study. (Lu G, Rao M, Zhu P, Liang B, El-Nazer RT, Fonkem E, Bhattacharjee MB, Zhu JJ) Front Neurol 2019;10:42 PMID: 30766509 PMCID: PMC6366009 SCOPUS ID: 2-s2.0-85065499617 02/16/2019       43 Citations
  • Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells. (Wang F, Zhou S, Qi D, Xiang SH, Wong ET, Wang X, Fonkem E, Hsieh TC, Yang J, Kirmani B, Shabb JB, Wu JM, Wu M, Huang JH, Yu WH, Wu E) J Am Chem Soc 2019 Feb 27;141(8):3613-3622 PMID: 30689374 SCOPUS ID: 2-s2.0-85061899738 01/29/2019       33 Citations
  • Current-controlled Nitinol wire for improved arterial navigation (Olafsen LJ, Jones B, Sparks L, Nguyen HH, Tanner A, Schubert KE, Olafsen JS, Dayawansa S, Fonkem E, Huang JH) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2019;10868 SCOPUS ID: 2-s2.0-85064388324 01/01/2019       1 Citation
  • Identification of a panel of genes as a prognostic biomarker for glioblastoma. (Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E) EBioMedicine 2018 Nov;37:68-77 PMID: 30341039 PMCID: PMC6284420 SCOPUS ID: 2-s2.0-85054789395 10/21/2018       40 Citations
  • Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013. (Ambe SN, Lyon KA, Nizamutdinov D, Fonkem E) Neurooncol Pract 2018 Aug;5(3):154-160 PMID: 30094045 PMCID: PMC6075522 SCOPUS ID: 2-s2.0-85055655957 08/11/2018       2 Citations
  • Management of Autoimmune Status Epilepticus. (Kirmani BF, Barr D, Robinson DM, Pranske Z, Fonkem E, Benge J, Huang JH, Ling G) Front Neurol 2018;9:259 PMID: 29867707 PMCID: PMC5954092 SCOPUS ID: 2-s2.0-85046999484 06/06/2018       10 Citations
  • Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma. (Nizamutdinov D, Stock EM, Dandashi JA, Vasquez EA, Mao Y, Dayawansa S, Zhang J, Wu E, Fonkem E, Huang JH) World Neurosurg 2018 Jan;109:e67-e74 PMID: 28951270 PMCID: PMC5729086 SCOPUS ID: 2-s2.0-85031810900 09/28/2017       62 Citations
  • Intravascular Lymphoma in the CNS: Options for Treatment. (Nizamutdinov D, Patel NP, Huang JH, Fonkem E) Curr Treat Options Neurol 2017 Aug 23;19(10):35 PMID: 28831736 PMCID: PMC5569665 SCOPUS ID: 2-s2.0-85028041323 08/24/2017       23 Citations
  • Texas Occurrence of Lyme Disease and Its Neurological Manifestations. (Dandashi JA, Nizamutdinov D, Dayawansa S, Fonkem E, Huang JH) J Neuroinfect Dis 2016 Jun;7(2) PMID: 27478852 PMCID: PMC4962872 08/02/2016    
  • Role of Anticonvulsants in the Management of Posttraumatic Epilepsy. (Kirmani BF, Robinson DM, Fonkem E, Graf K, Huang JH) Front Neurol 2016;7:32 PMID: 27047441 PMCID: PMC4801868 SCOPUS ID: 2-s2.0-84964664190 04/06/2016       15 Citations
  • Multiple dural-based hemangiopericytomas. (Stroberg E, Uhrbrock DH, Harris F, Mutyala S, DiPatre PL, Fonkem E) Proc (Bayl Univ Med Cent) 2016 Apr;29(2):191-3 PMID: 27034566 PMCID: PMC4790568 SCOPUS ID: 2-s2.0-85045941266 04/02/2016    
  • A retrospective analysis of meningioma in Central Texas. (Fonkem E, Dandashi JA, Stroberg E, Garrett D Jr, Harris FS, El Nihum IM, Cooper J, Dayawansa S, Huang JH) J Epidemiol Glob Health 2016 Jun;6(2):87-93 PMID: 26851351 PMCID: PMC7320443 SCOPUS ID: 2-s2.0-84959548773 02/07/2016       8 Citations
  • Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. (Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH) BMC Neurol 2016 Jan 16;16:9 PMID: 26849888 PMCID: PMC4744383 SCOPUS ID: 2-s2.0-84957096167 02/07/2016       58 Citations
  • Prognostication, treatment strategies and clinical outcomes in ependymoma diagnosed patients (Nizamutdinov D, Graf KC, Dayawansa S, Kirmani B, Wu E, Huang JH, Fonkem E) Ependymomas: Prognostic Factors, Treatment Strategies and Clinical Outcomes 1 January 2016:13-30 SCOPUS ID: 2-s2.0-85022083506 01/01/2016    
  • Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. (Ding X, Ma M, Teng J, Teng RK, Zhou S, Yin J, Fonkem E, Huang JH, Wu E, Wang X) Oncotarget 2015 Sep 15;6(27):24178-91 PMID: 26172304 PMCID: PMC4695178 SCOPUS ID: 2-s2.0-84943414298 07/15/2015       118 Citations
  • A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. (Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, Kohane IS, Wu JM, Wu M, Taylor MD, Wu E) Oncotarget 2015 Feb 20;6(5):2709-24 PMID: 25576913 PMCID: PMC4413612 SCOPUS ID: 2-s2.0-84923300161 01/13/2015       17 Citations
  • The natural history of intravascular lymphomatosis. (Fonkem E, Lok E, Robison D, Gautam S, Wong ET) Cancer Med 2014 Aug;3(4):1010-24 PMID: 24931821 PMCID: PMC4303169 SCOPUS ID: 2-s2.0-84929142394 06/17/2014       59 Citations
  • Selection of antiepileptic drugs in older people. (Kirmani BF, Robinson DM, Kikam A, Fonkem E, Cruz D) Curr Treat Options Neurol 2014 Jun;16(6):295 PMID: 24756539 SCOPUS ID: 2-s2.0-84957439344 04/24/2014       11 Citations
  • Clinical pharmacology and pharmacokinetics of levetiracetam. (Wright C, Downing J, Mungall D, Khan O, Williams A, Fonkem E, Garrett D, Aceves J, Kirmani B) Front Neurol 2013 Dec 04;4:192 PMID: 24363651 PMCID: PMC3850169 SCOPUS ID: 2-s2.0-84891649144 12/24/2013       76 Citations
  • The role of levetiracetam in treatment of seizures in brain tumor patients. (Fonkem E, Bricker P, Mungall D, Aceves J, Ebwe E, Tang W, Kirmani B) Front Neurol 2013 Oct 07;4:153 PMID: 24109474 PMCID: PMC3791389 SCOPUS ID: 2-s2.0-84885338717 10/11/2013       36 Citations
  • Efficacy and tolerability of intravenous levetiracetam in childrens. (Aceves J, Khan O, Mungall D, Fonkem E, Wright C, Wenner A, Kirmani B) Front Neurol 2013;4:120 PMID: 23966977 PMCID: PMC3743038 SCOPUS ID: 2-s2.0-84883535358 08/24/2013       10 Citations
  • Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. (Zhou S, Wang F, Wong ET, Fonkem E, Hsieh TC, Wu JM, Wu E) Curr Med Chem 2013;20(33):4095-101 PMID: 23931281 PMCID: PMC4102832 SCOPUS ID: 2-s2.0-84887963510 08/13/2013       103 Citations
  • Neurobehavioral effects of levetiracetam in brain tumor related epilepsy. (Bernett A, Phenis R, Fonkem E, Aceves J, Kirmani B, Cruz-Laureano D) Front Neurol 2013;4:99 PMID: 23885253 PMCID: PMC3717617 SCOPUS ID: 2-s2.0-84883524023 07/26/2013       12 Citations
  • Ethambutol toxicity exacerbating the phenotype of CMT2A2. (Fonkem E, Skordilis MA, Binkley EM, Raymer DS, Epstein A, Arnold WD, Kissel JT, Lawson VH) Muscle Nerve 2013 Jul;48(1):140-4 PMID: 23733358 SCOPUS ID: 2-s2.0-84879550022 06/05/2013       17 Citations
  • Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial. (Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A) Front Oncol 2012;2:122 PMID: 23087896 PMCID: PMC3472503 10/23/2012    
  • Melanoma brain metastasis: overview of current management and emerging targeted therapies. (Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET) Expert Rev Neurother 2012 Oct;12(10):1207-15 PMID: 23082737 SCOPUS ID: 2-s2.0-84867772278 10/23/2012       64 Citations
  • NovoTTF-100A: a new treatment modality for recurrent glioblastoma. (Fonkem E, Wong ET) Expert Rev Neurother 2012 Aug;12(8):895-9 PMID: 22708931 SCOPUS ID: 2-s2.0-84866640709 06/20/2012       57 Citations
  • Rare phenomenon of extracranial metastasis of glioblastoma. (Fonkem E, Lun M, Wong ET) J Clin Oncol 2011 Dec 01;29(34):4594-5 PMID: 22042941 SCOPUS ID: 2-s2.0-83355169749 11/02/2011       29 Citations
  • Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. (Bates ME, Liu LY, Esnault S, Stout BA, Fonkem E, Kung V, Sedgwick JB, Kelly EA, Bates DM, Malter JS, Busse WW, Bertics PJ) Am J Respir Cell Mol Biol 2004 May;30(5):736-43 PMID: 14630612 SCOPUS ID: 2-s2.0-2342480598 11/25/2003       48 Citations
    • Last update: 02/17/2024